Aktis Oncology


Aktis Oncology is a biotechnology company pioneering the discovery and development of a new class of targeted radiopharmaceuticals to treat a broad range of solid tumor cancers.

Employees

11-50

Links


Org chart

Matthew Roden
President & CEO
Collapse
Paul L. Feldman
Chief Scientific Officer
Pankaj Bhargava
Interim CMO
Karen Mccarthy
VP & Head of Finance
Lorraine Horgan
Executive Director & Head of Program Management
Carlos Rodriguez
Executive Director, Corporate Development
Janet Horton
Vice President
Akos Czibere M.D.
Chief Medical Officer

Board & advisors

Todd Foley
Co-Founder & Chairman
Helen Kim
Director
Lloyd M. Segal
Independent Director
Ken Herrmann
Chair, Scientific Advisory Board
Patrick Baeuerle
Co-Founder & Advisor
Jason Ruth
Board Observer
Kevin Raidy
Board Observer
Markus Reschke
Board Observer